Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10939618 | 1.00 | CYP1A2 (0.75) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL5313692 | 1.00 | CYP1A2 (0.75) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL1128098 | 0.98 | CYP1A2 (0.72) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL8202520 | 0.98 | CYP1A2 (0.72) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL812920 | 0.97 | CYP1A2 (0.71) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| Ethylene SCHEMBL27789472 | 0.95 | CYP1A2 (0.69) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL1720619 | 0.95 | CYP1A2 (0.68) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL3402164 | 0.92 | — | — | |
| Methylene Chloride SCHEMBL28294345 | 0.91 | CYP1A2 (0.63) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL23886232 | 0.90 | GLA (0.65) | CYP1A2MAPK1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003346-B1 | THE SERPINB3 INHIBITOR PIPERIDINEPROPIONIC ACID FOR TUMOR TREATMENT | UNIV DEGLI STUDI PADOVA (IT) | 2025-09-03 | — | — | EP | claimed |
| EP-4554585-A1 | PROTEASE ACTIVATED RECEPTOR 2 (PAR2) INHIBITOR AND ITS USES | Universita' Degli Studi Di Padova (IT) | 2025-05-21 | — | — | EP | claimed |
| WO-2025094676-A1 | COMPOSITION CONTAINING 1-PIPERIDINEPROPIONIC ACID AND GERANIUM THUNBERGII | 株式会社 資生堂 | 2025-05-08 | — | — | WO | claimed |
| CN-119781248-A | Negative photoresist composition and patterning method | 阜阳欣奕华新材料科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-20250041188-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2025-02-06 | — | — | US | claimed |
| US-20240423890-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2024-12-26 | — | — | US | claimed |
| EP-4442242-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2024-10-09 | — | — | EP | claimed |
| EP-4442325-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2024-10-09 | — | — | EP | claimed |
| CN-118524828-A | Sebum production inhibitor/promoter | 株式会社资生堂 | 2024-08-20 | — | — | CN | claimed |
| CN-118510489-A | External composition for skin | 株式会社资生堂 | 2024-08-16 | — | — | CN | claimed |
| WO-1999005319-A9 | METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY | RAPIGENE INC (US) | 1999-06-17 | — | — | WO | claimed |
| EP-0868535-A2 | METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES | Rapigene, Inc. (US) | 1998-10-07 | — | — | EP | claimed |
| EP-0850320-A2 | METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL | DARWIN MOLECULAR CORPORATION (US) | 1998-07-01 | — | — | EP | claimed |
| US-5707990-A | 2-substituted amino and thio alkyl benzoxazine antimicrobial agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1998-01-13 | — | — | US | claimed |
| WO-1997027331-A9 | METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES | — | 1997-10-09 | — | — | WO | claimed |
| WO-1997028167-A1 | 2-SUBSTITUTED AMINO AND THIO ALKYL BENZOXAZINE ANTIMICROBIAL AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1997-08-07 | — | — | WO | claimed |
| WO-1997027327-A2 | METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL | RAPIGENE, INC. (US) | 1997-07-31 | — | — | WO | claimed |
| WO-1997027331-A2 | METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES | RAPIGENE, INC. (US) | 1997-07-31 | — | — | WO | claimed |
| EP-0494956-B1 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS | COSAN CHEM CORP (US) | 1995-12-13 | — | — | EP | claimed |
| EP-0316809-B1 | Salts of amino-(poly)percarboxylic acids | AUSIMONT SPA (IT) | 1993-11-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041188-A1 | COSMETIC | GLA, ASAH2, SORD | CYP1A2 3209/4885MAPK1 3820/4885SMN1; SMN2 1347/4885 |
| US-20240423890-A1 | COSMETIC | TYR, RBP1, NISCH | CYP1A2 1217/4885MAPK1 1932/4885SMN1; SMN2 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.